Gold is generally regarded as a useful therapeutic agent in the treatment of rheumatoid arthritis. Unfortunately its administration, however carefully supervised, is attended by the risk of various toxic reactions, some of which may be fatal. Until the introduction of BAL, no specific treatment was available for such toxic reactions. Favourable results with this drug have lately been reported from America in twenty cases described by various authors, and in three cases in this country.
Research carried out by Peters and his colleagues (1945) led to the discovery of BAL, and to its use as a therapeutic agent in the treatment of toxic reactions to heavy metals. Further experimental work carried out in America confirmed and elaborated the findings of these workers (Waters and Stock, 1945) . Essentially, BAL acts by competing with tissue cells for certain metals. It forms with the metal a stable compound which is as a rule non-toxic and which is believed to be rapidly excreted. BAL proved highly successful in the prevention and treatment of lewisite burns (Stocken and Thompson, 1941; Vey, 1941) ; in the treatment of the complications of arseno-therapy (Carleton and others, 1946; Longcope and others, 1946) ; and in the treatment of acute mercury poisoning (Longcope and Luetscher, 1946) . The experimental work of Long and Farah (1946) suggests that it may be of use in severe reactions due to mercurial diuretics. BAL may also be found to be effective in poisoning due to the inhalation of zinc fumes (Annotation, Nature, 1946) , and may have an application in veterinary medicine in diseases of copper metabolism in sheep (McDonald, 1946) .
Among the first papers on the use of BAL in toxic reactions due to gold was that of Ragan and Boots (1947) . Before using the drug in human subjects suffering from gold toxicity these authors carried out an important preliminary experiment. While BAL combines with heavy metals to form a compound that as a rule is non-toxic, that compound formed with cadmium causes acute nephritis. Ragan and Boots demonstrated that animals treated simultaneously with gold and BAL showed no toxic effects in heart, liver, or kidney. BAL was then used in five cases of rheumatoid arthritis with gold dermatitis in man, with a good result in four instances. In all cases a significant increase in the urinary excretion of gold occurred coincident with the administration of BAL. Four patients had an exacerbation in symptoms due to rheumatoid arthritis within one month of this treatment. Cohen and others (1947) reported five cases, three with gold dermatitis, one with pruritus and conjunctivitis, and one with stomatitis, treated successfully with BAL. Margolis and Caplan (1947) found BAL of benefit in one case of severe stomatitis and in one case of mild conjunctivitis, anal ulceration, and dermatitis; they claimed amelioration of long-standing exfoliative dermatitis in two cases; in one case of mild dermatitis no appreciable benefit was obtained. Margolis and Caplan concluded that the early use of BAL in the treatment of toxic effects resulting from the administration of gold appeared to be of value. Davison (1947) successfully treated three early cases of gold dermatitis. Lockie and others (1947) Case 13.-A married woman, aged 51 years and weighing 47 kg., had suffered from rheumatic mitral stenosis, auricular fibrillation, and intermittent attacks of congestive heart failure for three years ; rheumatoid arthritis had been present for about the same length of time ; symptoms from the arthritis were severe and treatment with myochrysine was begun on Oct. 14, 1947. By 12 Dec. 0 38 g. had been given, with an improvement in the arthritis; the largest dose administered was 0 05 g. On Dec. 17 the patient complained of having felt profoundly exhausted for two or three days. She gave.the appearance of being a seriously ill woman. A slight icteric tinge was present and the urine contained urobilinogen in excess. The liver was not enlarged. The icteric index was 17 units (Meulengracht). *old hepatitis was diagnosed, and on Dec. 18 treatment with BAL was begun in successive daily doses of 200 mg., 300 mg., 300 mg., 300 mg., and 200 mg. There were no local reactions, but immediately after the last injection the patient complained of nausea, epigastric discomfort and some diarrhoea. BAL was stopped, and symptoms subsided within twenty-four hours.
Within forty-eight hours of the first injection there was marked subjective and objective improvement. Tiredness was less, and the icteric tinge disappeared. Urobilinogen was present in the urine in excess until Dec. It may be concluded, therefore, that in cases of gold toxicity, other than hepatitis, BAL may be administered in single doses of up to 4 mg. per kilo of body weight with minimal toxic reactions, and that such as occur will subside rapidly within one or at the most two hours. Such single large doses of BAL may therefore be given to out patients with equanimity provided the patient is kept under observation for about one hour after the injection. BAL used in this way may have a useful clinical application which will be discussed later.
Relapse in Rheumatoid Arthritis.-It has already been noted that Ragan and Boots (1947) found that four of their five cases showed an increase in the symptoms of rheumatoid arthritis within one month of treatment with BAL. In the present series six cases have been followed up for periods of one to six months and only one of these showed any relapse. This patient had previously relapsed following a course of gold without BAL.
Excretion of Gold.-The urinary excretion of gold was estimated by Dr. Crawford in the Department of Pharmacology, in three of the above cases using the method of Block and Buchanan (1940) . This was the method used by Ragan and Boots (1947) (Modell and others, 1946) . In the short courses recommended such reactions are unlikely, and they were not encountered in this series.
Summary and Conclusions Previous work on BAL with particular reference to its use in patients suffering from toxic reactions to gold is reviewed. The use of BAL in fifteen such cases is described.
BAL appears to be of value in the treatment of gold toxicity. In dermatitis the immediate improvement in the pruritus is a constant and striking feature, and the course of the eruption is probably influenced in a favourable manner. BAL is also effective in the treatment of stomatitis and hepatitis due to gold.
Toxic effects are minimal in doses up to four milligrammes per kilogramme of' body weight, except in cases of hepatitis-in which it is confirmed that BAL must be given in smaller doses if severe reactions are to be avoided.
Relapse of symptoms due to rheumatoid arthritis following the administration of BAL was not a feature of the present series.
No conclusion could be made about the excretion of gold in the urine following BAL therapy.
Recommendations are made about the dosage, partly from a consideration of the previous literature on the subject, and partly from the 'limited experience obtained in the present series of cases. A distinction is drawn between the use of the drug in the treatment of mild and severe toxic reactions. 
